These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27140676)

  • 1. Perfusion Cardiac Magnetic Resonance Imaging as a Rule-Out Test for Cardiac Allograft Vasculopathy.
    Chih S; Ross HJ; Alba AC; Fan CS; Manlhiot C; Crean AM
    Am J Transplant; 2016 Oct; 16(10):3007-3015. PubMed ID: 27140676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET assessment of myocardial perfusion reserve inversely correlates with intravascular ultrasound findings in angiographically normal cardiac transplant recipients.
    Wu YW; Chen YH; Wang SS; Jui HY; Yen RF; Tzen KY; Chen MF; Lee CM
    J Nucl Med; 2010 Jun; 51(6):906-12. PubMed ID: 20484427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.
    Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB
    J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular ultrasound of the proximal left anterior descending artery is sufficient to detect early cardiac allograft vasculopathy.
    Floré V; Brown AJ; Pettit SJ; West NEJ; Lewis C; Parameshwar J; Hoole SP
    Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29194769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy.
    Erbel C; Mukhammadaminova N; Gleissner CA; Osman NF; Hofmann NP; Steuer C; Akhavanpoor M; Wangler S; Celik S; Doesch AO; Voss A; Buss SJ; Schnabel PA; Katus HA; Korosoglou G
    JACC Cardiovasc Imaging; 2016 Mar; 9(3):255-66. PubMed ID: 26965729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy.
    Miller CA; Sarma J; Naish JH; Yonan N; Williams SG; Shaw SM; Clark D; Pearce K; Stout M; Potluri R; Borg A; Coutts G; Chowdhary S; McCann GP; Parker GJ; Ray SG; Schmitt M
    J Am Coll Cardiol; 2014 Mar; 63(8):799-808. PubMed ID: 24355800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation.
    Narang A; Blair JE; Patel MB; Mor-Avi V; Fedson SE; Uriel N; Lang RM; Patel AR
    Int J Cardiovasc Imaging; 2018 Oct; 34(10):1607-1617. PubMed ID: 29728952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrotic Plaque and Microvascular Dysfunction Predict Early Cardiac Allograft Vasculopathy Progression After Heart Transplantation: The Early Post Transplant Cardiac Allograft Vasculopathy Study.
    Chih S; Chong AY; Džavík V; So DY; Aleksova N; Wells GA; Bernick J; Overgaard CB; Stadnick E; Mielniczuk LM; Beanlands RSB; Ross HJ
    Circ Heart Fail; 2023 Jun; 16(6):e010173. PubMed ID: 37165901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac PET Myocardial Blood Flow Quantification Assessment of Early Cardiac Allograft Vasculopathy.
    Chih S; Tavoosi A; Nair V; Chong AY; Džavík V; Aleksova N; So DY; deKemp RA; Amara I; Wells GA; Bernick J; Overgaard CB; Celiker-Guler E; Mielniczuk LM; Stadnick E; McGuinty C; Ross HJ; Beanlands RSB
    JACC Cardiovasc Imaging; 2024 Jun; 17(6):642-655. PubMed ID: 37999656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
    Tomai F; De Luca L; Petrolini A; Di Vito L; Ghini AS; Corvo P; De Persio G; Parisi F; Pongiglione G; Giulia Gagliardi M; Prati F
    J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary imaging of cardiac allograft vasculopathy predicts current and future deterioration of left ventricular function in patients with orthotopic heart transplantation.
    Reddy SA; Khialani BV; Lambert B; Floré V; Brown AJ; Pettit SJ; West NE; Lewis C; Parameshwar J; Bhagra S; Kydd A; Hoole SP
    Clin Transplant; 2022 Feb; 36(2):e14523. PubMed ID: 34724254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular ultrasound-guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients.
    Nelson LM; Rossing K; Ihlemann N; Boesgaard S; Engstrøm T; Gustafsson F
    Clin Transplant; 2020 Dec; 34(12):e14124. PubMed ID: 33068292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular ultrasound for cardiac allograft vasculopathy detection.
    Mendiz OA; Gamboa P; Renedo MF; Lev GA; Favaloro LE; Bertolotti AM
    Clin Transplant; 2021 Feb; 35(2):e14167. PubMed ID: 33237578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative flow ratio computed from invasive coronary angiography as a predictor for cardiac allograft vasculopathy after cardiac transplant.
    Shah H; Lee I; Rao S; Suddath W; Rodrigo M; Mohammed S; Molina E; García-Garcia HM; Kenigsberg BB
    Int J Cardiovasc Imaging; 2024 Feb; 40(2):451-458. PubMed ID: 38117378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for early development of cardiac allograft vasculopathy by intravascular ultrasound.
    Moayedi Y; Fan CPS; Tremblay-Gravel M; Miller RJH; Kawana M; Henricksen E; Parizo J; Wainwright R; Fearon WF; Ross HJ; Khush KK; Teuteberg JJ
    Clin Transplant; 2020 Nov; 34(11):e14098. PubMed ID: 32970884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance for Noninvasive Detection of Microcirculatory Disease Associated With Allograft Vasculopathy: Intracoronary Measurement Validation.
    Mirelis JG; García-Pavía P; Cavero MA; González-López E; Echavarria-Pinto M; Pastrana M; Segovia J; Oteo JF; Alonso-Pulpón L; Escaned J
    Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):571-8. PubMed ID: 25522835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of cardiac allograft vasculopathy assessed with coronary angiography versus coronary vascular ultrasound and virtual histology.
    Torres HJ; Merello L; Ramos SA; Aninat MA; Becerra LE; Mora AD; Valenzuela PT; Godoy MJ; Prieto AA
    Transplant Proc; 2011; 43(6):2318-21. PubMed ID: 21839263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of dobutamine stress echocardiography in the detection of cardiac allograft vasculopathy in heart transplant recipients: A systematic review and meta-analysis study.
    Elkaryoni A; Abu-Sheasha G; Altibi AM; Hassan A; Ellakany K; Nanda NC
    Echocardiography; 2019 Mar; 36(3):528-536. PubMed ID: 30726558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac allograft vasculopathy after heart transplantation: electrocardiographically gated cardiac CT angiography for assessment.
    Mittal TK; Panicker MG; Mitchell AG; Banner NR
    Radiology; 2013 Aug; 268(2):374-81. PubMed ID: 23657888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.